VIA
PFE icon

Vantage Investment Advisors’s Pfizer PFE Stock Holding History

Vantage Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$7.19M Buy
173,003
+7,622
+5% +$293K 1.51% 25
2018
Q2 		$5.69M Buy
165,381
+6,213
+4% +$212K 1.38% 31
2018
Q1 		$5.36M Sell
159,168
-11,736
-7% -$403K 1.36% 30
2017
Q4 		$5.87M Buy
170,904
+10,699
+7% +$365K 1.35% 23
2017
Q3 		$5.43M Buy
160,205
+6,276
+4% +$202K 1.4% 23
2017
Q2 		$4.91M Buy
153,929
+48,963
+47% +$1.54M 1.42% 29
2017
Q1 		$3.41M Buy
104,966
+18,318
+21% +$578K 1.12% 34
2016
Q4 		$2.67M Buy
86,648
+2,692
+3% +$82.2K 1.08% 35
2016
Q3 		$2.7M Buy
83,956
+8,537
+11% +$285K 1.2% 31
2016
Q2 		$2.52M Buy
75,419
+1,757
+2% +$56.1K 1.06% 30
2016
Q1 		$2.07M Buy
73,662
+16,377
+29% +$468K 0.92% 33
2015
Q4 		$1.75M Buy
57,285
+5,878
+11% +$185K 0.88% 34
2015
Q3 		$1.53M Buy
51,407
+1,896
+4% +$60.8K 0.86% 33
2015
Q2 		$1.57M Sell
49,511
-40,618
-45% -$1.32M 0.87% 32
2015
Q1 		$2.98M Buy
90,129
+43,408
+93% +$1.38M 0.84% 36
2014
Q4 		$1.38M Buy
46,721
+9
+0% +$258 0.78% 34
2014
Q3 		$1.31M Sell
46,712
-2,675
-5% -$75.1K 0.8% 35
2014
Q2 		$1.39M Buy
49,387
+867
+2% +$24.7K 0.85% 35
2014
Q1 		$1.48M Buy
48,520
+4,712
+11% +$140K 0.98% 33
2013
Q4 		$1.27M Buy
+43,808
New +$1.27M 0.87% 36

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vantage Investment Advisors's PFE Position: Q3 2018 in Review

Vantage Investment Advisors increased its Pfizer (PFE) stake by 4.6% in Q3 2018, buying an estimated $293K and bringing the position to 173,003 shares worth $7.19M. The position accounts for 1.51% of the portfolio, ranked #25.

Vantage Investment Advisors first reported a position in PFE in Q4 2013 and has held it in 20 quarters since. 2,256 funds tracked by Wall St. Rank hold PFE as of Q3 2018.

  • Vantage Investment Advisors held 173,003 shares of Pfizer worth $7.19M as of Q3 2018.
  • Vantage Investment Advisors bought 7,622 Pfizer shares in Q3 2018, an estimated $293K.
  • Pfizer made up 1.51% of Vantage Investment Advisors's portfolio in Q3 2018, its #25 holding.
  • Vantage Investment Advisors first reported a position in Pfizer in Q4 2013 and has held it in 20 quarters since.
  • 2,256 funds tracked by Wall St. Rank held Pfizer as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.